brodalumab - Articles and news items

Amgen

Brodalumab treatment improved clinical signs and symptoms in Phase 2 psoriatic arthritis study published in The New England Journal Of Medicine

Industry news / 12 June 2014 / Amgen

Phase 3 program underway to further assess Brodalumab as potential treatment for people living with psoriatic arthritis…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+